These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12010228)

  • 1. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.
    Mattiasson A; Abrams P; Van Kerrebroeck P; Walter S; Weiss J
    BJU Int; 2002 Jun; 89(9):855-62. PubMed ID: 12010228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.
    Asplund R; Sundberg B; Bengtsson P
    BJU Int; 1999 Apr; 83(6):591-5. PubMed ID: 10233563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women.
    Lose G; Lalos O; Freeman RM; van Kerrebroeck P;
    Am J Obstet Gynecol; 2003 Oct; 189(4):1106-13. PubMed ID: 14586363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study.
    van Kerrebroeck P; Rezapour M; Cortesse A; Thüroff J; Riis A; Nørgaard JP
    Eur Urol; 2007 Jul; 52(1):221-9. PubMed ID: 17280773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.
    Yamaguchi O; Nishizawa O; Juul KV; Nørgaard JP
    BJU Int; 2013 Mar; 111(3):474-84. PubMed ID: 23046147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
    Fu FG; Lavery HJ; Wu DL
    Neurourol Urodyn; 2011 Mar; 30(3):312-6. PubMed ID: 21305590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Sand PK; Dmochowski RR; Reddy J; van der Meulen EA
    J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP; Herschorn S; Albei CD; van der Meulen EA
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect.
    Hvistendahl GM; Riis A; Nørgaard JP; Djurhuus JC
    BJU Int; 2005 Apr; 95(6):804-9. PubMed ID: 15794787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.
    Weiss JP; Zinner NR; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2012 Apr; 31(4):441-7. PubMed ID: 22447415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL; Stokes A; Salzman PM
    J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program.
    Yamaguchi O; Juul KV; Falahati A; Yoshimura T; Imura F; Kitamura M
    Low Urin Tract Symptoms; 2020 Jan; 12(1):8-19. PubMed ID: 31397969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ; Stokes A; Turner KL
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.
    Wang CJ; Lin YN; Huang SW; Chang CH
    J Urol; 2011 Jan; 185(1):219-23. PubMed ID: 21074790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity.
    Lee HW; Choo MS; Lee JG; Park CH; Paick JS; Lee JZ; Han DH; Park WH; Lee KS
    J Korean Med Sci; 2010 Dec; 25(12):1792-7. PubMed ID: 21165296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin: in adults with nocturia.
    Cvetković RS; Plosker GL
    Drugs; 2005; 65(1):99-107; discussion 108-9. PubMed ID: 15610055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study.
    Rovner ES; Raymond K; Andruczyk E; Juul KV
    Low Urin Tract Symptoms; 2018 Sep; 10(3):221-230. PubMed ID: 28560762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials.
    Kaminetsky J; Fein S; Dmochowski R; MacDiarmid S; Abrams S; Cheng M; Wein A
    J Urol; 2018 Sep; 200(3):604-611. PubMed ID: 29654805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
    Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ
    J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.